SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Acquisition

22 Jun 2015 07:00

RNS Number : 7766Q
Caledonia Investments PLC
22 June 2015
Β 

ο»Ώ

Β 

Β 

Β 

CALEDONIA INVESTMENTS AGREES TO ACQUIRE SEVEN INVESTMENT MANAGEMENT

Β 

Caledonia Investments plc ("Caledonia") is pleased to announce that it has agreed to acquire a majority stake in Seven Investment Management ("7IM"), the provider of discretionary fund management, retail investment funds and platform services to UK investors, in a transaction which values the business at Β£100m.

Β 

7IM was established in 2002 by its co-founders, Chief Executive Officer, Tom Sheridan, and Head of Corporate Development, Justin Urquhart Stewart, along with their Chief Finance Officer, Charles Sparrow, and has grown from its seven founder members to a team of more than 190 people. At 30 April 2015, it had assets under management and administration of approximately Β£9.5bn.

Β 

Dependent on the date of completion, which is subject to the Financial Conduct Authority's approval, Caledonia will invest up to Β£77m in cash to acquire approximately 94% of 7IM Holdings Ltd ("7IM Holdings"), the controlling member of Seven Investment Management LLP which operates the 7IM business, from its current owners, Allied Zurich Holdings Ltd and Aegon UK plc. 7IM's management team will subscribe Β£5.0m for the remaining equity, with the balance of the purchase costs to be provided by Β£25m of bank debt, which Caledonia has agreed to underwrite in the event that this is not in place by completion.

Β 

For its financial year to 31 December 2014, 7IM Holdings reported profit before tax of Β£8.6m and gross assets of Β£42.9m.

Β 

Commenting on the acquisition, Duncan Johnson, Caledonia's Head of Unquoted Investments, said:

Β 

"Caledonia has a long history of investing in successful fund management businesses. We look forward to supporting Tom Sheridan and his team in building on 7IM's impressive growth record and strong investment performance to service an expanding UK wealth management market where there is a growing demand for multi-asset and multi-manager funds."

Β 

Tom Sheridan, 7IM's Chief Executive, commented:

Β 

"We are delighted to be partnering with Caledonia in the next phase of 7IM's development. Their investment philosophy and culture, as well as their attitude to longer term investment, are perfectly aligned with our own. This will enable us to continue our focus on, and development of, "doing the right thing" in our business, for not just our partners and staff, but of course most importantly our clients.

Β 

My colleagues are also pleased to have the opportunity to be providing further investment into the business alongside Caledonia. We have many exciting developments and ideas for our clients, 7IM and our industry, and having Caledonia as a partner will greatly help us in achieving some very exciting goals."

Β 

22 June 2015

 

For further information contact:

Β 

Β 

Caledonia Investments plc

+44 20 7802 8080

Will Wyatt,

Chief Executive

Β 

Stephen King,

Finance Director

Β 

Duncan Johnson,

Head of Unquoted Investments

Media contact:

Tulchan Communications

+44 20 7353 4200

Peter Hewer

Β 

END

Β 

Notes for editors:

Β 

Caledonia Investments plc

Caledonia is a self-managed investment trust company listed on the London Stock Exchange with net assets of approximately Β£1.6bn. The company maintains a concentrated portfolio of international quoted, unquoted and fund investments and has paid an increasing annual dividend for 48 years.

Β 

In the unquoted arena, Caledonia seeks to invest Β£25m to Β£100m in private companies, either on a majority or minority basis, providing a meaningful presence and growth capital supporting double-digit operating margins. Its current unquoted portfolio includes Park Holidays (a UK caravan parks operator), Cobehold (a European unquoted investment house), TGE Marine (a marine gas-engineering business based in Germany), The Sloane Club (a London residential club) and Choice Care Group (a UK learning disability care homes provider).

Β 

For additional information on Caledonia, please visit www.caledonia.com.

Β 

7IM

7IM was founded in 2002 by its current management team and specialises in multi-asset risk-rated investment, which it offers through discretionary fund management, asset management and self-invest services. At 30 April 2015, 7IM had assets under management and administration of approximately Β£9.5bn.

Β 

For additional information on 7IM, please visit www.7im.co.uk.

Β 

Transaction

Caledonia's investment in 7IM was led by Charlie Edwards, Duncan Johnson, Tim Lewis and Tarquin Wethered.

Β 

Macfarlanes (Stephen Drewitt) and N M Rothschild & Sons (Ed Griffin) respectively acted as legal and financial advisers to Caledonia. PricewaterhouseCoopers (Fredrik Johansson) provided commercial due diligence advice and Deloitte (Tim Haden) provided tax advice. KPMG (James Woolf) provided financial due diligence services.

Β 

Evercore (Ollie Clayton) and Clifford Chance (Alex Erasmus) respectively provided corporate finance and legal advice to Allied Zurich Holdings Ltd and Aegon UK plc.

Β 

Squire Patton Boggs (Nick Allen) provided legal advice to 7IM's management team.

Β 

Β 

Β 

Neither the contents of Caledonia's nor 7IM's websites, nor the contents of any website accessible from hyperlinks on these websites (or any other website) is incorporated into, or forms part of, this announcement.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQPGUPUQUPAGGG
Date   Source Headline
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)
20th Apr 20239:40 amRNSAcquisition
12th Apr 202310:42 amRNSResponse to press speculation
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20229:22 amRNSNet Asset Value(s)
22nd Nov 20227:00 amRNSDirectorate Change
22nd Nov 20227:00 amRNSHalf-year Report
7th Nov 202210:49 amRNSNet Asset Value(s)
7th Oct 20227:00 amRNSUnaudited net asset value and portfolio update
30th Sep 20224:21 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:51 pmRNSDirector/PDMR Shareholding
6th Sep 202210:17 amRNSNet Asset Value(s)
23rd Aug 20225:21 pmRNSDirector/PDMR Shareholding
15th Aug 20222:21 pmRNSDirector Declaration
4th Aug 202212:41 pmRNSNet Asset Value(s)
27th Jul 20224:47 pmRNSResult of AGM
19th Jul 20224:59 pmRNSDirector Declaration
7th Jul 20227:00 amRNSUnaudited net asset value and portfolio update
23rd Jun 20224:00 pmRNSAnnual Financial Report
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
16th Jun 20224:32 pmRNSDirector/PDMR Shareholding
14th Jun 20221:51 pmRNSDirector/PDMR Shareholding
8th Jun 20229:36 amRNSNet Asset Value(s)
6th Jun 20223:33 pmRNSDirector/PDMR Shareholding
31st May 20224:50 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSFinal Results
6th May 20229:02 amRNSNet Asset Value(s)
7th Apr 20227:00 amRNSUnaudited net asset value and portfolio update
4th Apr 202210:10 amRNSDirectorate Change
25th Mar 20224:47 pmRNSDirector/PDMR Shareholding
21st Mar 20223:56 pmRNSDirector/PDMR Shareholding
16th Mar 20222:05 pmRNSDirector/PDMR Shareholding
7th Mar 20227:00 amRNSDirectorate Change
7th Mar 20227:00 amRNSNet Asset Value(s)
28th Feb 20224:59 pmRNSTotal Voting Rights
4th Feb 20224:56 pmRNSTransaction in Own Shares
4th Feb 20229:52 amRNSNet Asset Value(s)
31st Jan 20225:23 pmRNSTotal Voting Rights
28th Jan 20225:25 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.